Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Goss

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Biomedical Mass Spectrometry|November 1, 1983
Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metaboliteM Jarman, A B Foster, P E Goss, et al.
Cancer Research|September 1, 1986
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical responseJ R Wilkinson, J C Williams, D Singh, et al.
Steroids|July 1, 1987
4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancerR C Coombes, P E Goss, M Dowsett, et al.
Leukemia & Lymphoma|July 27, 2016
Gastrointestinal Non-Hodgkin's LymphomaA K Stewart, F A Shepherd, P E Goss, et al.
Cancer Research|September 1, 1986
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II reportP E Goss, T J Powles, M Dowsett, et al.
Breast (Edinburgh, Scotland)|April 9, 2016
New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole - Analyses from NCIC CTG MA.17P E R Liedke, D Tu, L Shepherd, et al.
Seminars in Oncology|April 1, 1990
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary reportF A Shepherd, P E Goss, J Latreille, et al.
Cancer Research|April 1, 1987
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and routeM Dowsett, P E Goss, T J Powles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2006
Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancerB Moy, D Tu, J L Pater, et al.
Breast (Edinburgh, Scotland)|December 6, 2006
Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifenC M Vachon, J N Ingle, V J Suman, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Biomedical Mass Spectrometry|November 1, 1983
Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metaboliteM Jarman, A B Foster, P E Goss, et al.
Cancer Research|September 1, 1986
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical responseJ R Wilkinson, J C Williams, D Singh, et al.
Steroids|July 1, 1987
4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancerR C Coombes, P E Goss, M Dowsett, et al.
Leukemia & Lymphoma|July 27, 2016
Gastrointestinal Non-Hodgkin's LymphomaA K Stewart, F A Shepherd, P E Goss, et al.
Cancer Research|September 1, 1986
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II reportP E Goss, T J Powles, M Dowsett, et al.
Breast (Edinburgh, Scotland)|April 9, 2016
New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole - Analyses from NCIC CTG MA.17P E R Liedke, D Tu, L Shepherd, et al.
Seminars in Oncology|April 1, 1990
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary reportF A Shepherd, P E Goss, J Latreille, et al.
Cancer Research|April 1, 1987
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and routeM Dowsett, P E Goss, T J Powles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2006
Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancerB Moy, D Tu, J L Pater, et al.
Breast (Edinburgh, Scotland)|December 6, 2006
Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifenC M Vachon, J N Ingle, V J Suman, et al.
Pageof 8